News Image

Nuvectis Pharma, Inc. Reports First Quarter 2025 Financial Results and Business Highlights

Provided By GlobeNewswire

Last update: May 6, 2025

FORT LEE, N.J., May 06, 2025 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (NASDAQ: NVCT) ("Nuvectis" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of innovative precision medicines for the treatment of serious conditions of unmet medical need in oncology, today reported its financial results for the first quarter 2025 and provided an update on recent business progress.

Read more at globenewswire.com

NUVECTIS PHARMA INC

NASDAQ:NVCT (6/9/2025, 8:00:02 PM)

After market: 8.85 0 (0%)

8.85

0 (0%)



Find more stocks in the Stock Screener

Follow ChartMill for more